Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Brand
1.1.2. End users
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Brand outlook
2.2.3. End Users outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Artificial Urinary Sphincter Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of urinary incontinence
3.2.1.2. Increasing healthcare expenditure in developing countries
3.2.1.3. Technological advancement
3.2.2. Market restraint analysis
3.2.2.1. Shortage of skilled health care professionals
3.2.2.2. Stringent government regulations
3.3. Artificial Urinary Sphincter Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. Artificial Urinary Sphincter Market: Brand Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. AMS 800
4.1.2. Others
4.2. Brand Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Artificial Urinary Sphincter Market by Brand Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. AMS 800
4.5.1.1. AMS 800 market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Others
4.5.2.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Artificial Urinary Sphincter: End-user Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Male
5.1.2. Female
5.2. End Users Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global Artificial Urinary Sphincter Market by End-user Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Male
5.5.1.1. Male market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Female
5.5.2.1. Female market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Artificial Urinary Sphincter Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2018 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. U.S. market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Canada market estimates and forecast, 2018 – 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. UK market estimates and forecast, 2018 – 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Germany market estimates and forecast, 2018 – 2030 (USD Million)
6.6.3. France
6.6.3.1. France market estimates and forecast, 2018 – 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Italy market estimates and forecast, 2018 – 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Spain market estimates and forecast, 2018 – 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Norway market estimates and forecast, 2018 – 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Sweden market estimates and forecast, 2018 – 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Denmark market estimates and forecast, 2018 – 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Japan market estimates and forecast, 2018 – 2030 (USD Million)
6.7.2. China
6.7.2.1. China market estimates and forecast, 2018 – 2030 (USD Million)
6.7.3. India
6.7.3.1. India market estimates and forecast, 2018 – 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Australia market estimates and forecast, 2018 – 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. South Korea market estimates and forecast, 2018 – 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Thailand market estimates and forecast, 2018 – 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Brazil market estimates and forecast, 2018 – 2030 (USD Million)
6.8.2. Mexico
6.8.2.1. Mexico market estimates and forecast, 2018 – 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Argentina market estimates and forecast, 2018 – 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. South Africa market estimates and forecast, 2018 – 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Saudi Arabia market estimates and forecast, 2018 – 2030 (USD Million)
6.9.3. UAE
6.9.3.1. UAE market estimates and forecast, 2018 – 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Kuwait market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2022
7.3.4. Boston Scientific Corporation
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Creo Medical Ltd.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Zephyr Surgical Implant.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Rules-Based Medicine.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. GT Urological (GTU)
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
